HOPE by SOLTI is a leading real-world clinical practice study in Spain that assesses the impact of using comprehensive genomic data on treatment decision-making for patients with locally advanced or metastatic breast cancer. It is highly relevant for its patient empowerment approach that has exceeded participation expectations.
DIPCAN aims to change clinical practice in the area of oncology by combining clinical, imaging, anatomopathological, and genomic data to identify certain patients who could be more likely to better respond to treatment. Genomcore provides its technological framework to process and integrate all datasets into a single database for AI model development.
SYNLAB, the largest European clinical laboratory and medical diagnostic services provider, partners with Genomcore to have an end-to-end solution to automate workflows, reduce results turnaround time and provide exceptional efficiency in laboratory genetic diagnostic services.
Made of Genes is an innovative molecular health service that uses genetic, blood, and health questionnaire data to offer personalized care recommendations. Backed by Genomcore, their low-code platform allows for easy integration with health providers, turning scientific knowledge into actionable precision health insights.
The AGATA study is the first genomic screening platform for advanced breast cancer ever attempted in Spain. By this molecular platform SOLTI aimed to increase the likelihood of a patient being included in a targeted clinical trial based on the tumor molecular profiling. Genomcore provided a secure and compliant federated platform to store and analyze the clinical and genomic data within the project.
RAD51predict is a research project that evaluates RAD51 test as a predictive tool to improve diagnosis, classify tumors and help guide treatment decision-making. Genomcore provides a secure and compliant federated data repository to store and analyze multimodal datasets within the project.
In this project, wearables were used to monitor physical activity and improve the health and independence of citizens over 65 in Andorra. Genomcore’s multi-modal platform allowed data interoperability, including wearable data retrieval and integration, data storage and analytics for precision health analyses.
BIOS launched the “Origen” project to promote precision and personalized medicine in Colombia through the study of genetics. Genomcore provided the technological framework for the pilot project that used exome sequencing data to perform individual genetic risk assessment.
